Back
Recombinant human luteinizing hormone supplementation may improve embryo quality in in vitro fertilization/intracytoplasmic sperm injection cycles with gonadotropin-releasing hormone antagonist protocol
Amir Wiser, Ariel Hourvitz, Yoav Yinon, Jacob Levron, Jehoshua Dor, Shai Elizur
Open J. Obstet. Gynecol. Vol.1 No.2, June 30, 2011  DOI: 10.4236/ojog.2011.12007
       (PDF  95K)     HTML     
The Effect of Recombinant LH Addition to Recombinant FSH on Assisted Reproductive Technologies Outcomes in Overweight and Obese Patients without Polycystic Ovary Syndrome
Merve Demir, Emre Sertel, Ozge Senem Yucel Cicek, Leylim Yalcınkaya, Sare Dogan, Osman Onur Daloglu, Emek Doger, Birol Vural
Open J. Obstet. Gynecol. Vol.10 No.4, March 31, 2020  DOI: 10.4236/ojog.2020.1040039
       (PDF  317K)     HTML      XML
GnRH Antagonist Protocol: Is It Optimal for All Patients of Different Ages Undergoing In Vitro Fertilization and Embryo Transfer?
Weijie Xing, Haiyan Lin, Qingxue Zhang
Adv. Sex. Med. Vol.7 No.4, September 22, 2017  DOI: 10.4236/asm.2017.74012
       (PDF  1160K)     HTML      XML
FSH/LH Ratio as a Predictor of the IVF Outcome in Young Women
Eman Shaeer, Ahmed M. Maged, Dina Shaheen, Hala Gomaa
Open J. Obstet. Gynecol. Vol.8 No.10, August 23, 2018  DOI: 10.4236/ojog.2018.810085
       (PDF  278K)     HTML      XML
Late hCG administration yields more good quality embryos and favors the overall IVF outcome
Pu Zhang, Kjell Wånggren
Open J. Obstet. Gynecol. Vol.2 No.4, November 09, 2012  DOI: 10.4236/ojog.2012.24070
       (PDF  171K)     HTML     
 
 
Top